Risks and benefits of weaning immunosuppression in liver transplant recipients: Long-term follow-up

Transplantation Proceedings

Volumn 29, Issue 1-2, 1997, Pages 1174-1177

  Mazariegos, G V ^a,b   Reyes, J ^a   Marino, I ^a   Flynn, B ^a   Fung, J J ^a   Starzl, I E ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; PREDNISONE; TACROLIMUS;

CLINICAL PROTOCOL; CONFERENCE PAPER; DRUG WITHDRAWAL; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SURVIVAL; TREATMENT OUTCOME;

CHILD; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; TIME FACTORS;

EID: 0030977875     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(96)00535-0     Document Type: Conference Paper

References (13)

1. Starzl TE, Demetris AJ, Trucco M, et al: Hepatology 17:1127, 1993
2. Ramos HC, Reyes J, Abu-Elmagd K, et al: Transplantation 59:212, 1995
3. Mazariegos GV, Ramos H, Shapiro R, et al: Transplant Proc 27:207, 1995
4. Ware JE, Sherbourne CD: Med Care 36:473, 1992
5. Starzl TE, Demetris AJ, Murase N, et al: Lancet 339:1579, 1992
6. Qian S, Demetris AJ, Murase N, et al: Hepatology 19:916, 1994
7. Starzl TE, Demetris AJ, Murase N, et al: Immunol Today (in press)
8. Schlitt HJ, Hundrieser J, Ringe B, et al: N Engl J Med 330:646, 1994
9. Anand AC, Hubscher SG, Gunson BK, et al: Transplantation 60:1098, 1995
10. Molleston JP, Alevy YG, Sivasai KSR, et al: Transplantation 61:656, 1996
11. Demetris AJ, Fung JJ, Todo S, et al: Transplantation 53:1056, 1992
12. Sanborn WJ, Hay JE, Porayko MK, et al: Hepatology 19:925, 1994
13. Pappo O, Ramos H, Starzl TE, et al: Am J Surg Path 19:192, 1995